Development and Validation of a Risk-Calculator for Adverse Perioperative Outcomes for Women with Ovarian Cancer

BACKGROUND: Primary cytoreduction followed by platinum based chemotherapy is the primary treatment for advanced ovarian cancer. However neoadjuvant chemotherapy followed by interval debulking is an alternative option, particularly in those who may be poor surgical candidates. OBJECTIVE: The objectiv...

Full description

Saved in:
Bibliographic Details
Published in:Am J Obstet Gynecol
Main Authors: CHAM, Stephanie, CHEN, Ling, ST. CLAIR, Caryn M., HOU, June Y., TERGAS, Ana I., MELAMED, Alexander, ANANTH, Cande V., NEUGUT, Alfred I., HERSHMAN, Dawn L., WRIGHT, Jason D.
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6545148/
https://ncbi.nlm.nih.gov/pubmed/30771346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2019.02.019
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items